News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
201,395 Results
Type
Article (8339)
Company Profile (16)
Press Release (193036)
Multimedia
Podcasts (12)
Webinars (8)
Section
Business (76312)
Career Advice (456)
Deals (11037)
Drug Delivery (24)
Drug Development (22235)
Employer Resources (53)
FDA (4245)
Job Trends (4099)
News (113170)
Policy (8205)
Tag
Academia (698)
Accelerated approval (7)
Adcomms (12)
Allergies (38)
Alliances (13196)
ALS (37)
Alzheimer's disease (509)
Antibody-drug conjugate (ADC) (96)
Approvals (4393)
Artificial intelligence (142)
Autoimmune disease (27)
Automation (6)
Bankruptcy (73)
Best Places to Work (3462)
BIOSECURE Act (3)
Biosimilars (47)
Biotechnology (7)
Bladder cancer (32)
Brain cancer (10)
Breast cancer (139)
Cancer (1368)
Cardiovascular disease (87)
Career advice (387)
Career pathing (10)
CAR-T (56)
CDC (4)
Celiac Disease (1)
Cell therapy (165)
Cervical cancer (13)
Clinical research (19644)
Collaboration (442)
Compensation (50)
Complete response letters (7)
COVID-19 (543)
CRISPR (17)
C-suite (247)
Cystic fibrosis (31)
Data (1850)
Decentralized trials (1)
Denatured (6)
Depression (11)
Diabetes (128)
Diagnostics (2084)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (15)
Drug discovery (62)
Drug pricing (25)
Drug shortages (3)
Duchenne muscular dystrophy (40)
Earnings (44323)
Editorial (7)
Employer branding (8)
Employer resources (49)
Events (28602)
Executive appointments (283)
FDA (5107)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (281)
Gene editing (35)
Generative AI (15)
Gene therapy (121)
GLP-1 (172)
Government (1005)
Grass and pollen (2)
Guidances (221)
Healthcare (5073)
HIV (21)
Huntington's disease (6)
IgA nephropathy (21)
Immunology and inflammation (36)
Immuno-oncology (17)
Indications (40)
Infectious disease (604)
Inflammatory bowel disease (51)
Influenza (26)
Intellectual property (73)
Interviews (67)
IPO (5620)
IRA (3)
Job creations (807)
Job search strategy (351)
JPM (8)
Kidney cancer (10)
Labor market (10)
Layoffs (81)
Leadership (8)
Legal (1503)
Liver cancer (23)
Longevity (2)
Lung cancer (232)
Lymphoma (138)
Machine learning (13)
Management (20)
Manufacturing (192)
MASH (31)
Medical device (4270)
Medtech (4288)
Mergers & acquisitions (5633)
Metabolic disorders (262)
Multiple sclerosis (45)
NASH (1)
Neurodegenerative disease (83)
Neuropsychiatric disorders (9)
Neuroscience (811)
NextGen: Class of 2026 (1596)
Non-profit (1231)
Now hiring (5)
Obesity (111)
Opinion (54)
Ovarian cancer (40)
Pain (32)
Pancreatic cancer (55)
Parkinson's disease (110)
Partnered (7)
Patents (103)
Patient recruitment (104)
Peanut (22)
People (19354)
Pharmaceutical (9)
Pharmacy benefit managers (1)
Phase 1 (5220)
Phase 2 (8311)
Phase 3 (7433)
Pipeline (1740)
Policy (35)
Postmarket research (801)
Preclinical (2156)
Press Release (12)
Prostate cancer (77)
Psychedelics (7)
Radiopharmaceuticals (93)
Rare diseases (166)
Real estate (1515)
Recruiting (21)
Regulatory (6785)
Reports (9)
Research institute (680)
Resumes & cover letters (64)
Rett syndrome (6)
RSV (17)
Schizophrenia (39)
Series A (48)
Series B (36)
Service/supplier (1)
Sickle cell disease (19)
Spinal muscular atrophy (29)
Sponsored (13)
Startups (790)
Stomach cancer (5)
Supply chain (22)
Tariffs (16)
The Weekly (6)
Vaccines (223)
Venture capital (17)
Weight loss (48)
Women's health (17)
Worklife (5)
Date
Last 7 days (152)
Last 30 days (545)
Last 365 days (8172)
2026 (697)
2025 (8203)
2024 (9526)
2023 (11497)
2022 (15264)
2021 (16581)
2020 (15851)
2019 (13690)
2018 (10475)
2017 (10629)
2016 (9636)
2015 (11911)
2014 (8436)
2013 (6523)
2012 (7170)
2011 (7664)
2010 (6719)
Location
Africa (261)
Alabama (38)
Arizona (52)
Arkansas (1)
Asia (15024)
Australia (2705)
California (2619)
Canada (918)
China (443)
Colorado (135)
Connecticut (84)
Delaware (77)
Europe (32748)
Florida (457)
Georgia (97)
Hawaii (2)
Idaho (23)
Illinois (226)
India (24)
Indiana (160)
Iowa (3)
Japan (170)
Kansas (24)
Kentucky (8)
Louisiana (16)
Maine (51)
Maryland (331)
Massachusetts (1817)
Michigan (105)
Minnesota (176)
Missouri (40)
Montana (12)
Nebraska (6)
Nevada (41)
New Hampshire (28)
New Jersey (986)
New Mexico (6)
New York (740)
North Carolina (402)
North Dakota (2)
Northern California (1230)
Ohio (74)
Oklahoma (5)
Oregon (6)
Pennsylvania (566)
Puerto Rico (7)
Rhode Island (7)
South America (441)
South Carolina (20)
Southern California (1132)
Tennessee (26)
Texas (353)
United States (9921)
Utah (91)
Virginia (34)
Washington D.C. (14)
Washington State (218)
West Virginia (1)
Wisconsin (33)
Wyoming (2)
201,395 Results for "sri international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
N4 Pharma collaboration with SRI International demonstrates Nuvec® nanoparticle successfully targets lung cancer cells
October 1, 2025
·
3 min read
Biotech Bay
Synfini, Inc. Spins Out of SRI International to Bring Novel Molecular Discovery Platform to Market
Synfini, Inc. announced that it has acquired rights to the patented Synfini® platform from SRI International®, and that it will operate as an independent firm.
September 26, 2023
·
4 min read
Biotech Bay
SRI International Will Receive Renowned Research Center PARC from Xerox
SRI International, an independent nonprofit research institute behind countless cutting-edge technological advances, announced it will receive the Palo Alto Research Center, a Xerox company and technology pioneer.
April 24, 2023
·
3 min read
Biotech Bay
Xerox Announces Donation of Palo Alto Research Center (PARC) to SRI International
Xerox Holdings Corporation announced the donation of the Palo Alto Research Center to SRI International, a nonprofit research institute behind some of the world’s most impactful deep tech advancements.
April 24, 2023
·
4 min read
Business
SRI International Appoints Kathlynn Brown to Biosciences Division President
SRI International, an independent nonprofit research institute behind countless cutting-edge technological advances, announced the promotion of Kathlynn Brown to President of its Biosciences Division.
January 31, 2023
·
2 min read
N4 Pharma announces collaboration with SRI to target and treat cells in the human body that have been previously unreachable
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system designed to carry nucleotides to be developed as cancer treatments and vaccines, has entered into a research collaboration agreement with SRI, an independent nonprofit research institute based in Silicon Valley, California
April 26, 2024
·
4 min read
Business
SRI International Announces Collaboration Agreement with Janssen
SRI International (SRI) today announced the company has entered into a collaboration agreement with Janssen Pharmaceutica NV (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
January 5, 2022
·
2 min read
Job Trends
Talent Acquisition Leaders Reframe Recruiting, Focus On Internal Mobility
Talent acquisition leaders at leading pharma and biotech organizations are leveraging technologies
,
including automation
,
to develop internal talent marketplaces and systems that support upskilling and reskilling their workforce.
BioSpace
spoke to leaders at Pfizer and Bayer about their evolving approach to resourcing.
September 24, 2025
·
3 min read
·
Chantal Dresner
Business
Codexis Announces Appointment of Sri Ryali as Chief Financial Officer
Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of Sri Ryali as Chief Financial Officer effective immediately.
January 23, 2023
·
4 min read
Press Releases
Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform
February 5, 2026
·
2 min read
1 of 20,140
Next